Q uantitative coronary arteriography is now routinely used in studies assessing arterial remodelling in response to interventions such as lipid lowering and percutaneous transltinal coronary angioplasty. Although this methodology provides both relative and absolute measurements that can be evaluated statistically as continuous variables, it is, however, often desirable or necessary to establish categorical responses to the interventions based on the variability inherent in the quantitative methods (i.e., it is often necessary to state whether individual patients, as opposed to entire groups, have "restenosed," "progressed, " "regressed," and so forth, and these categorical designations are based on critical limits of variability).lv2 These limits are generally based on an analysis of a rather diverse range of lesion severity, and the question arises as to whether the variability of measuring changes in lesion or segment morphology is affected by the initial severity of the lesion being studied. It is con-
Q uantitative coronary arteriography is now routinely used in studies assessing arterial remodelling in response to interventions such as lipid lowering and percutaneous transltinal coronary angioplasty. Although this methodology provides both relative and absolute measurements that can be evaluated statistically as continuous variables, it is, however, often desirable or necessary to establish categorical responses to the interventions based on the variability inherent in the quantitative methods (i.e., it is often necessary to state whether individual patients, as opposed to entire groups, have "restenosed," "progressed, " "regressed," and so forth, and these categorical designations are based on critical limits of variability).lv2 These limits are generally based on an analysis of a rather diverse range of lesion severity, and the question arises as to whether the variability of measuring changes in lesion or segment morphology is affected by the initial severity of the lesion being studied. It is con- ceivable that variability may be greater at 1 end than at the other end of the spectrum of lesion severity. If this is true, then the use of 1 critical value to designate whether a subject has responded in a certain way would be inap propriate, and this designation would be better achieved by using criteria that more directly reflect the measurement variability of lesions of a specified, initial severity. This report examines whether the variability of measuring morphologic parameters of stenoses is affected by the baseline severity of the lesion.
Records of digitally archived cineangiographic image frames (1 view) of narrowings previously acquired were retrospectively reviewed to establish a data set of 50 lesions distributed evenly among 5 categories of percent each severity subgroup and for each anatomic measurement, correlation coefficient (r value), accuracy (mean differences between the 2 measurements, retaining the direction of the difference), precision (standard deviation of mean differences) and mean absolute difference (mean absolute difference between measurements; i.e., direction of the difference was ignored) were calculated. For these analyses, the first set of measurements was considered the standard by which the second set was compared. In contrast to other reportq2 this study reflects only the variability that can be ascribed to baseline lesion severity and does not include the increased variability that can be expected when frame reselection and redigitization are involved. Correlation coefficients were assessed using a Bonferroni-adjusted Fisher's Z transformation. Repeated measures analysis of variance was used for assessing accuracy and mean absolute difference values. In the case of mean absolute differences, a Newman-Keuls simultaneous comparisons test was used to determine which subgroups were significantly different. Precision was assessed using a Hartley test for heterogeneous variances. Results were considered significant at p cO.05. Table Z shows the study results and includes an assessment of the overall variability in the entire cohort. There were no significant differences among any of the absolute measures of stenosis severity. The mean absolute difference of the percent diameter stenosis parameter was higher in the 21 to 40% severity group than in the 61 to 80% one (4.0 f 2.4% us 1.4 f 1.1%; p <O.Ol). These 2 values were not significantly different from any of the other mean absolute difference values (range 2.2 to 2.4%) in the other subgroups.
This study demonstrates that the variability of absolute stenosis dimensions is not significantly affected by the initial severity of the stenosis being measured. The percent diameter stenosis measurement showed a minor tendency to be more variable in the modest (21 to 40%) than in a more severe (61 to 80%) group. This was manifest as a statistically significant difference in the mean absolute difference in repeated measures and was supported by a lower (although not significantly) correlation coefficient. Therefore, this study suggests that 1 categorical criterion can be used to assess responses to therapy and intervention, which are not affected by the initial severity of the lesion when absolute measurements are used. For most purposes, the same probably applies to measures of percent diameter stenosis. However, it may be prudent for investigators interested in following a particular subset of stenoses (e.g., "new lesion formation") to create quantitative limits for categoric determinations based specifically on the range of severity of the type of lesion to be investigated. 4 H igh levels of factor VII (FVII) coagulant activity (FVIIc) have been associated with an increased risk of coronary artery disease and cardiac death, and are thought to be of greater significance than cholesterol in the first 5 years after screening.' These studies have mainly been performed in Western countries and the subjects were generally adults aged <65 years. Japan is one of the countries where the incidence of coronary artery disease is 10w,~ and we have recently reported on FVII hyperactivity in the elderly Japanese.3 This time, to study the relation between coronary artery disease and FVII in elderly Japanese persons, we performed electrocardiography and measured FVIIc and FVII antigen (FVIIag) levels as well as blood lipid fractions. A total of 317 elderly Japanese subjects (>60 years old), who were residents of a local home for the aged, were studied. Fifty-one of the 127 subjects (40%) with hypertension ana' 27 of the 37 subjects (73%) with diabetes mellitus were receiving medication. Eighteen subjects received antihyperlipidemic agents. An electrocardiogram was recorded in all subjects. Subjects who did not have hypertension, diabetes mellitus, peripheral vascular disease, hyperlipidemia, a history of stroke, or an ischemic electrocardiographic tracing were classified as the healthy elderly group (82 men, mean age 77 f 9 years; 62 women, mean age 80 f 7 years). Blood samples were collected after a 12-hour fast. FVZZc was assayed by an automated l-stage method (Coag-stat, Kyoto Daiichi Pharmacological Co.), using human FVZZ-defycienl plasma (Dade, France) and rabbit calcified thromboplastin reagent (Thromboplastin C, Dade, France). FVZZag was, assayed by an ELZSA (Diagnostica Stago, France). In briefi diluted plasma samples or calibulators (normal plasma pool of 20 nonsmoking men aged <30 years) were added to the microwells that had been coated
